Previous studies regarding immunohistological evaluation of β-catenin activation using expression of GS which is a well-known target of β-catenin suggested that not only HCC with CTNNB1 mutations but also others without such mutations showed GS overexpression. Here, CTNNB1 is linked to hepatocellular carcinoma.